Basilico F, Di Silvestre D, Sedini S, Petretto A, Levreri I, Melioli G, Farina C, Mori F, Mauri P L
Institute for Biomedical Technologies-CNR, Proteomics and Metabolomics Unit, Via Fratelli Cervi, 93, 20090, Segrate (MI), Italy.
J Mass Spectrom. 2007 Mar;42(3):288-92. doi: 10.1002/jms.1160.
The identification of hemoglobin (Hb) variants is usually performed by means of different analytical steps and methodologies. Phenotypic methods, such as gel electrophoresis and high performance liquid chromatography, are used to detect the different electrophoretic or chromatographic behaviors of hemoglobin variants in comparison to HbA0 used as a control. These data often need to be combined with mass spectrometry analyses of intact globins and their tryptic peptide mixtures. As an alternative to a 'step-by-step' procedure, we have developed a 'single step' approach for the identification of Hb variants present in biological samples. This is based on the microHPLC-ESI-MS/MS analysis of the peptide mixture generated by a tryptic digestion of diluted Hb samples and an in-house new database containing solely the variant tryptic peptide of known human Hb variants. The experimental results (full MS and MS/MS spectra) are correlated with theoretical mass spectra generated from our in-house-built variant peptide database (Hbp) using the SEQUEST algorithm. Simple preparation of samples and an automated identification of the variant peptide are the main characteristics of this approach, making it an attractive method for the detection of Hb variants at the routine clinical level. We have analyzed 16 different samples, each containing a different known variant of hemoglobin.
血红蛋白(Hb)变体的鉴定通常通过不同的分析步骤和方法来进行。表型方法,如凝胶电泳和高效液相色谱,用于检测与作为对照的HbA0相比血红蛋白变体的不同电泳或色谱行为。这些数据通常需要与完整珠蛋白及其胰蛋白酶肽混合物的质谱分析相结合。作为“逐步”程序的替代方法,我们开发了一种“单步”方法来鉴定生物样品中存在的Hb变体。这基于对稀释的Hb样品进行胰蛋白酶消化产生的肽混合物的微HPLC-ESI-MS/MS分析以及一个仅包含已知人类Hb变体的变体胰蛋白酶肽的内部新数据库。实验结果(全质谱和串联质谱谱图)使用SEQUEST算法与从我们内部构建的变体肽数据库(Hbp)生成的理论质谱相关联。样品制备简单以及变体肽的自动鉴定是该方法的主要特点,使其成为常规临床水平检测Hb变体的一种有吸引力的方法。我们分析了16个不同的样品,每个样品都含有不同的已知血红蛋白变体。